PetVivo Holdings, Inc.

PETV Healthcare Medical Devices

PetVivo Holdings, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 million, up 0.80% from fiscal 2025. In the quarter to June 2026, revenue grew 13.5%, EPS grew 44.4% and free cash flow grew 40.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

0.75 0.01 +1.35%
Market cap
$12.9M
P/E
0.0×
Fwd P/E
−1.2×
Dividend yield
—
F-score
3/9
Altman Z
−38.64
Beneish M
−8.74
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 4 2 2
ROE
(420.98%) (763.00%) (339.61%) (405.06%)
ROA
(228.51%) (272.64%) (168.43%) (214.99%)
ROIC
(148.31%) (159.26%) (283.42%) (447.24%)
Return on Tangible Assets
(626.60%) (1,189.11%) (1,391.85%) (13,738.77%)
Average Days of Receivables
35.75 76.31 224.06 25.88
Free Cash Flow per Share
(0.22) (0.20) (0.20) (0.15)
Free Cash Flow
(6.08) (6.57) (6.13) (5.45)
Other line items

Show all line items

Columns are period end dates